Fed officials say the central bank will ‘stick to its guns’, despite softening inflation
Meta’s artificial intelligence robot is consistently inconsistent as it learns from the internet
Home affairs minister Aaron Motsoaledi says digitisation will speed up the processing of applying for unabridged birth and marriage certificates
The premier announced her cabinet after a meeting with the ANC’s deployment committee and its alliance partners
The UK shopping centre owner says rent collection has returned to pre-Covid-19 levels, while it is seeing encouraging signs for retailer turnover
Stats SA says ongoing power cuts limited recovery in the sector and reduced production volumes
The improved sentiment is a result of increased merchandise export and import volumes and more new vehicles sold, Sacci report says
Labour shortages, soaring energy costs and Russia’s war in Ukraine are propelling prices for kitchen staples to new records, dragging family finances along for the ride
Fiery hooker comes in as coach Jacques Nienaber reshuffles front row for All Blacks showdown
The Italian SUV outguns the Bentley Bentayga's record
An SA study suggests there is less risk of hospital admission and severe illness in people infected with the Omicron coronavirus variant than with Delta variant, though the authors say that is probably due to an extent to high population immunity.
Questions about Omicron’s virulence are at the heart of scientific and political debate in many countries, as governments grapple with how to respond to the spread of the variant while researchers race to understand it.
The new study, which has not been peer-reviewed, was to assess the severity of disease by comparing data on Omicron infections in October and November with data on Delta infections from April to November, all in SA.
The analysis was carried out by a group of scientists from the National Institute for Communicable Diseases (NICD) and major universities including University of the Witwatersrand and University of KwaZulu-Natal.
They used data from four sources: national Covid-19 case data reported to the NICD, public sector laboratories, one large private sector lab and genome data for clinical specimens sent to NICD from private and public diagnostic labs across the country.
The authors found the risk of hospital admission was roughly 80% lower for those infected with Omicron compared with Delta, and that for those in hospital the risk of severe disease was roughly 30% lower.
However, they included several caveats and cautioned against jumping to conclusions about the intrinsic characteristics of Omicron.
“It is difficult to disentangle the relative contribution of high levels of previous population immunity versus intrinsic lower virulence to the observed lower disease severity,” they wrote.
Paul Hunter, a professor of medicine at Britain’s University of East Anglia, described the SA study as important. He said it was the first properly conducted study to appear in preprint form on the issue of Omicron versus Delta severity.
But Hunter said its main weakness was that it compared Omicron data from one period with Delta data from an earlier period.
“So even though cases of Omicron were less likely to end up in hospital than cases of Delta, it is not possible to say whether this is due to inherent differences in virulence or whether this is due to higher population immunity in November compared to earlier in the year,” he said.
“To a certain extent this does not matter to the patient who only cares that they won't get very sick. But it is important to know to enable improved understanding of the likely pressures on health services.”
Results of a major study by Imperial College London released last week showed there was no sign that Omicron was milder than Delta, though data on hospitalisations remains very limited. It has not been peer reviewed and published in a medical journal.
Would you like to comment on this article? Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.